Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000735057 | SCV000863247 | likely benign | not specified | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000872001 | SCV001782870 | likely benign | not provided | 2020-05-19 | criteria provided, single submitter | clinical testing | In-frame deletion in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002061022 | SCV002378607 | likely benign | Axenfeld-Rieger syndrome type 3 | 2022-10-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000872001 | SCV004700753 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | FOXC1: BS1 |
Prevention |
RCV003892679 | SCV004711192 | benign | FOXC1-related disorder | 2019-10-31 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |